preloader

EXPLANATORY NOTE

F.No. 8(48)/2003-DP/NPPA-Div.-II

National Pharmaceutical Pricing Authority
Ministry of Chemicals & Fertilizers
Government of India

2E/21, Jhandewalan Extn.,
New Delhi-110 055
Dated : 14th July, 2003

Explanatory Note

The National Pharmaceutical Pricing Authority has fixed/revised the prices of 94 formulation packs on 9th July, 2003. The prices have been fixed for the first time in the case of 12 formulation packs. In the case of 75 packs the price has been revised downwards ranging from 0.26% to 61.92%. The revision in prices was warranted due to downward revision in the price of various scheduled bulk drugs. There is no change of price in respect of 1 pack. In the case of 6 packs the price has increased ranging from 0.10% to 17.87% due to upward revision in the prices of raw materials.

Of the 94 formulation packs, ceiling prices (exclusive of excise duty and local taxes etc.) have been fixed in respect of 52 packs which are applicable to all the manufacturers of all such formulations including SSI Units. Non-ceiling prices (inclusive of excise duty but exclusive of local taxes etc.) have been fixed in respect of 42 packs. The prices have been fixed/revised in accordance with the provisions of the Drugs Price Control Order (DPCO), 1995 and as per the established criteria and guidelines. A copy of the statement showing the existing and revised prices (where available) is enclosed herewith.

Prices have been fixed/revised for Insulin-based formulation used in the treatment of diabetics, Prednisolone-based formulations used as carticosteroids, Erythromycin-based formulations used as Anti-biotic, Vitamin-based formulations used in diseases caused by deficiency of vitamins, Cefotaxime-based formulations used as anti-bacterial and Aspirin-based formulations used as analgesic.

The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.  Necessary revised price list is to be issued by the manufacturers/importers required under sub paragraph (3) of paragraph 14 of the DPCO, 1995.  Accordingly, as per the provisions of the DPCO, the revised price list in Form-V is to be furnished by the concerned manufacturer(s) to the government/NPPA, State Drug Control Authorities and distributors, wholesalers and retailers or any other agent.

The manufacturers are also required to work out the pro-rata prices of different pack sizes as the case may be in terms of S.O. No. 83 (E) dated 27.01.98.

(S. K. BHATT)
Dy. Director

Last Page Updated: 05-06-2019